Concepedia

Publication | Open Access

Clinical Response and Pattern of B cell Suppression with Single Low Dose Rituximab in Nephrology

DOIFull Paper Access

15

Citations

43

References

2020

Year

Jacob George, S Alex, E. T. Arun Thomas, Noble Gracious, Nalanda S. Vineetha, Sajeev Kumar
Kidney360

Abstract

Low-dose rituximab induces sustained depletion of CD19 B cells for up to 90 days. Its role in preventing relapses in SDNS, FRNS, MN, and rejection needs further study.

References

YearCitations

Page 1